Physician

Adam T Nomberg, MD

According to 2025 Medicare claims, Adam Nomberg, MD (NPI: 1851393847) practices ophthalmology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is ADAM T. NOMBERG, M.D, P.C. (NPI: 1467595397) and primary practice location at 11803-1311. Nomberg is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Nomberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 518 traditional Medicare patients, billed 1,909 HCPCS/CPT codes, and received $114,154 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 1,201 prescription claims across 244 beneficiaries totaling $320,510 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 14 records totaling $402. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $113,179 to $320,510. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$61K$122K2015 Medicare payment: $93,852 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $97,672 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $107,099 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $100,065 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $107,020 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $94,058 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $101,059 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $118,485 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $122,378 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $114,154 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154001,296$93,852
20164221,396$97,672
20174331,548$107,099
20184171,458$100,065
20194261,559$107,020
20203841,395$94,058
20214061,438$101,059
20224881,672$118,485
20235041,805$122,378
20245181,909$114,154

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$163K$326K2015 Drug cost: $113,179 (USD; Tot_Drug_Cst)2016 Drug cost: $126,901 (USD; Tot_Drug_Cst)2017 Drug cost: $162,014 (USD; Tot_Drug_Cst)2018 Drug cost: $172,812 (USD; Tot_Drug_Cst)2019 Drug cost: $192,937 (USD; Tot_Drug_Cst)2020 Drug cost: $204,951 (USD; Tot_Drug_Cst)2021 Drug cost: $222,608 (USD; Tot_Drug_Cst)2022 Drug cost: $280,355 (USD; Tot_Drug_Cst)2023 Drug cost: $326,438 (USD; Tot_Drug_Cst)2024 Drug cost: $320,510 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015158658$113,179
2016167712$126,901
2017171789$162,014
2018181787$172,812
2019163785$192,937
2020178836$204,951
2021162819$222,608
2022207978$280,355
20232331,071$326,438
20242441,201$320,510

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system291363$93
92012Established patient problem focused exam of visual system233648$67
92083Exam of visual field with extended testing184277$47
92250Photography of the retina140140$27
92133Imaging of optic nerve169171$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost17412,969$118,226
RhopressaNetarsudil Mesylate582,960$31,332
Alphagan PBrimonidine Tartrate372,992$23,931
RestasisCyclosporine141,200$23,310
VyzultaLatanoprostene Bunod321,810$16,966

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$402Tarsus Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam T. Nomberg, MD?

Tedicare shows public-source Medicare data for Adam T. Nomberg, MD (NPI 1851393847), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam T. Nomberg, MD have ACO affiliation data?

Adam T. Nomberg, MD is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Adam T. Nomberg, MD?

Adam T. Nomberg, MD is linked to ADAM T. NOMBERG, M.D, P.C. (billing NPI 1467595397) in the available physician profile data.

Does Adam T. Nomberg, MD have Open Payments data?

Adam T. Nomberg, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.